149 related articles for article (PubMed ID: 10850573)
1. Recombinant activated factor VII in children with acute bleeding resulting from liver failure and disseminated intravascular coagulation.
Chuansumrit A; Chantarojanasiri T; Isarangkura P; Teeraratkul S; Hongeng S; Hathirat P
Blood Coagul Fibrinolysis; 2000 Apr; 11 Suppl 1():S101-5. PubMed ID: 10850573
[TBL] [Abstract][Full Text] [Related]
2. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
Yilmaz D; Karapinar B; Balkan C; Akisü M; Kavakli K
Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474
[TBL] [Abstract][Full Text] [Related]
3. Treatment of intra-abdominal bleeding with recombinant activated factor VII in a patient with disseminated intravascular coagulation secondary to septic shock.
Martínez J; Cid AR; de la Rubia J; Gimeno R
Blood Coagul Fibrinolysis; 2005 Jun; 16(4):297-9. PubMed ID: 15870551
[TBL] [Abstract][Full Text] [Related]
4. Use of recombinant activated factor VII for bleeding in pancreatitis: a case series.
Laffan MA; Tait RC; Blatný J; Espersen K; Grabowska I; Loch-Bakoñska L; Pauzkowska A; Stasiak-Pikula E; Michalska G; Wendon J; Piotrowska K
Pancreas; 2005 Apr; 30(3):279-84. PubMed ID: 15782108
[TBL] [Abstract][Full Text] [Related]
5. Pediatric off-label use of recombinant factor VIIa.
Alten JA; Benner K; Green K; Toole B; Tofil NM; Winkler MK
Pediatrics; 2009 Mar; 123(3):1066-72. PubMed ID: 19255041
[TBL] [Abstract][Full Text] [Related]
6. Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.
Brenner B; Wiis J
Hematology; 2007 Feb; 12(1):55-62. PubMed ID: 17364994
[TBL] [Abstract][Full Text] [Related]
7. Potential role of recombinant activated factor VII for the treatment of severe bleeding associated with disseminated intravascular coagulation: a systematic review.
Franchini M; Manzato F; Salvagno GL; Lippi G
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):589-93. PubMed ID: 17890943
[TBL] [Abstract][Full Text] [Related]
8. Recombinant activated Factor VII as a hemostatic agent in very low birth weight preterms with gastrointestinal hemorrhage and disseminated intravascular coagulation.
Fischer D; Schloesser R; Buxmann H; Veldman A
J Pediatr Hematol Oncol; 2008 May; 30(5):337-42. PubMed ID: 18458565
[TBL] [Abstract][Full Text] [Related]
9. [Clinical assessment of potential fields of application of recombinant factor VIIa in internal and pediatric diseases. Recommendations of an expert group].
Dempfle CE; Gulba D; Kirchmaier CM; Klamroth R; Korte W; Lorenz R; Peck-Radosavljevic M; Veldman A; Zotz RB
Med Klin (Munich); 2007 Jan; 102(1):70-81. PubMed ID: 17221356
[TBL] [Abstract][Full Text] [Related]
10. Failure of recombinant factor VIIa to correct the coagulopathy in a case of severe postpartum hemorrhage.
Lewis NR; Brunker P; Lemire SJ; Kaufman RM
Transfusion; 2009 Apr; 49(4):689-95. PubMed ID: 19347977
[TBL] [Abstract][Full Text] [Related]
11. The use of recombinant activated factor VII in the treatment of massive pulmonary hemorrhage in a preterm infant.
Cetin H; Yalaz M; Akisu M; Karapinar DY; Kavakli K; Kultursay N
Blood Coagul Fibrinolysis; 2006 Apr; 17(3):213-6. PubMed ID: 16575260
[TBL] [Abstract][Full Text] [Related]
12. Control of bleeding in children with Dengue hemorrhagic fever using recombinant activated factor VII: a randomized, double-blind, placebo-controlled study.
Chuansumrit A; Wangruangsatid S; Lektrakul Y; Chua MN; Zeta Capeding MR; Bech OM;
Blood Coagul Fibrinolysis; 2005 Nov; 16(8):549-55. PubMed ID: 16269927
[TBL] [Abstract][Full Text] [Related]
13. Recombinant Factor VIIa Reduces Bleeding after Blunt Liver Injury in a Pig Model of Dilutional Coagulopathy under Severe Hypothermia.
Spronk HM; Braunschweig T; Rossaint R; Wüst DC; van Oerle R; Lauritzen B; Tolba R; Grottke O
PLoS One; 2015; 10(6):e0113979. PubMed ID: 26098426
[TBL] [Abstract][Full Text] [Related]
14. The use of recombinant activated factor VII for controlling life-threatening bleeding in Dengue Shock Syndrome.
Chuansumrit A; Tangnararatchakit K; Lektakul Y; Pongthanapisith V; Nimjaroenniyom N; Thanarattanakorn P; Wongchanchailert M; Komwilaisak P
Blood Coagul Fibrinolysis; 2004 Jun; 15(4):335-42. PubMed ID: 15166920
[TBL] [Abstract][Full Text] [Related]
15. The effect of recombinant factor VIIa on coagulopathic pigs with grade V liver injuries.
Schreiber MA; Holcomb JB; Hedner U; Brundage SI; Macaitis JM; Hoots K
J Trauma; 2002 Aug; 53(2):252-7; discussion 257-9. PubMed ID: 12169930
[TBL] [Abstract][Full Text] [Related]
16. Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors.
Santagostino E; Morfini M; Rocino A; Baudo F; Scaraggi FA; Gringeri A
Thromb Haemost; 2001 Oct; 86(4):954-8. PubMed ID: 11686352
[TBL] [Abstract][Full Text] [Related]
17. Treatment of acute bleeds with recombinant activated factor VII during immune tolerance therapy.
Petrini P; Klementz G
Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S143-6. PubMed ID: 9819046
[TBL] [Abstract][Full Text] [Related]
18. Factor VIIa in puerperal hemorrhage with disseminated intravascular coagulation.
Pepas LP; Arif-Adib M; Kadir RA
Obstet Gynecol; 2006 Sep; 108(3 Pt 2):757-61. PubMed ID: 17018493
[TBL] [Abstract][Full Text] [Related]
19. Recombinant activated factor VII in hemophagocytic lymphohistiocytosis with disseminated intravascular coagulation.
Zhuang JL; Jiang QW; Xu Y; Wang SJ
Chin Med J (Engl); 2011 Oct; 124(19):3189-91. PubMed ID: 22040579
[TBL] [Abstract][Full Text] [Related]
20. [Successful application of recombinant activated factor VII in a patient with HELLP syndrome and disseminated intravascular coagulation].
Ilić-Mostić T; Argirović R; Sparić R; Ljubić A; Bozanović T; Jeremić K; Tomanović-Koković J; Kadija S
Srp Arh Celok Lek; 2008 Sep; 136 Suppl 3():253-8. PubMed ID: 19562879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
